SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target.
Yuan S, Chu H, Chan JF, Ye ZW, Wen L, Yan B, Lai PM, Tee KM, Huang J, Chen D, Li C, Zhao X, Yang D, Chiu MC, Yip C, Poon VK, Chan CC, Sze KH, Zhou J, Chan IH, Kok KH, To KK, Kao RY, Lau JY, Jin DY, Perlman S, Yuen KY.
Yuan S, et al. Among authors: yip c.
Nat Commun. 2019 Jan 10;10(1):120. doi: 10.1038/s41467-018-08015-x.
Nat Commun. 2019.
PMID: 30631056
Free PMC article.